These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6602675)

  • 21. Immune complexes in the pericardial fluid in systemic lupus erythematosus.
    Quismorio FP
    Arch Intern Med; 1980 Jan; 140(1):112-4. PubMed ID: 6965447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibronectin mediates cell attachment to C1q: a mechanism for the localization of fibrosis in inflammatory disease.
    Rennard SI; Chen YF; Robbins RA; Gadek JE; Crystal RG
    Clin Exp Immunol; 1983 Oct; 54(1):239-47. PubMed ID: 6604609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.
    Uwatoko S; Mannik M
    J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.
    Erhardt CC; Mumford P; Maini RN
    Ann Rheum Dis; 1984 Jun; 43(3):451-6. PubMed ID: 6611139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    Clin Immunol Immunopathol; 1984 Jan; 30(1):104-16. PubMed ID: 6421520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of fibronectin on the processing of C1q- and C3b/bi-coated immune complexes by peripheral blood monocytes.
    Sorvillo JM; Gigli I; Pearlstein E
    J Immunol; 1986 Feb; 136(3):1023-6. PubMed ID: 3484498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune complexes in SLE.
    Inman RD
    Clin Rheum Dis; 1982 Apr; 8(1):49-62. PubMed ID: 6214365
    [No Abstract]   [Full Text] [Related]  

  • 31. Possible mechanisms of degradation of C1q in vivo and in vitro: role of macrophages.
    Daha MR
    Behring Inst Mitt; 1989 Jul; (84):42-6. PubMed ID: 2529843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryoimmunoglobulinaemia in patients with primary renal disease and systemic lupus erythematosus. I. IgG- and DNA-binding assessed by co-precipitation.
    McPhaul JJ
    Clin Exp Immunol; 1978 Jan; 31(1):131-40. PubMed ID: 639345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of fibronectin with C1q and collagen. Effects of ionic strength and denaturation of the collagenous component.
    Ingham KC; Landwehr R; Engel J
    Eur J Biochem; 1985 Apr; 148(2):219-24. PubMed ID: 3872795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The binding site for C1q on IgG.
    Duncan AR; Winter G
    Nature; 1988 Apr; 332(6166):738-40. PubMed ID: 3258649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
    Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
    J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryoglobulin studies in systemic lupus erythematosus.
    Sikander F; Salgaonkar DS; Joshi VR
    J Postgrad Med; 1989 Jul; 35(3):139-43. PubMed ID: 2634754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E; Kralikova P
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The C1q subunit of the first component of complement binds to laminin: a mechanism for the deposition and retention of immune complexes in basement membrane.
    Bohnsack JF; Tenner AJ; Laurie GW; Kleinman HK; Martin GR; Brown EJ
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3824-8. PubMed ID: 2987948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.